To include your compound in the COVID-19 Resource Center, submit it here.

Anti-CD19 chimeric antigen receptor: Phase I data

Data from 19 patients with various subtypes of DLBCL in an NIH-funded

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE